STOCK TITAN

Fusemachines Inc. 424B Filings

FUSE NASDAQ

Every 424B that Fusemachines Inc. (FUSE) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 424B covers the supplement that carries the terms of a priced offering, so if you follow FUSE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full FUSE filings page.

Rhea-AI Summary

Fusemachines Inc. is updating its shelf prospectus to cover a primary offering of up to 9,487,500 shares of common stock issuable upon exercise of an equal number of public warrants at $11.50 per share, and a secondary resale of up to 26,548,715 shares of common stock by selling stockholders, including 6,201,531 issuable from private placement warrants. As of June 30, 2026, the company had $3.2 million in assets, $20.5 million in liabilities, and a stockholders’ deficit of $17.4 million. Revenue for the six months ended June 30, 2026 was $3.7 million with a net loss of $3.7 million. Cash declined to $0.4 million, and management discloses substantial doubt about the company’s ability to continue as a going concern without additional capital. There were 28,985,302 shares of common stock outstanding as of August 6, 2026, and the stock and public warrants trade on Nasdaq under “FUSE” and “FUSEW.”

Rhea-AI Summary

Fusemachines Inc. is registering a primary offering of up to 9,487,500 shares of common stock issuable upon exercise of an equal number of public warrants at an exercise price of $11.50 per share, and a secondary resale of up to 26,548,715 shares of common stock, including 6,201,531 shares underlying private placement warrants. The company provides enterprise AI solutions and services across North America, Latin America and Asia and is listed on Nasdaq under “FUSE” and “FUSEW”.

For the quarter ended March 31, 2026, Fusemachines generated $1.88 million in revenue and reported a net loss attributable to common stakeholders of $0.96 million, or $(0.03) per share. Cash and cash equivalents were $1.77 million, total assets $4.94 million, total liabilities $19.98 million, and stockholders’ deficit $(15.03) million, with 28,939,240 common shares outstanding as of May 14, 2026.

Management discloses that recurring losses, negative operating cash flows and the current cash position raise substantial doubt about the company’s ability to continue as a going concern within one year. In April 2026, Fusemachines entered into a committed equity facility providing for up to $20 million of additional equity financing, but no proceeds have been received and effectiveness of the related registration has not yet occurred.

Rhea-AI Summary

Fusemachines Inc. files a prospectus supplement registering up to 9,487,500 shares of Common Stock to be issued upon exercise of public warrants at an exercise price of $11.50 per share and the resale of up to 26,548,715 shares of Common Stock by selling stockholders, including 6,201,531 shares issuable upon exercise of private placement warrants. The company also filed its Annual Report on Form 10-K, which discloses going concern language: cash of $4,221 thousand, net cash used in operations of $5,529 thousand for the year ended December 31, 2025, and an accumulated deficit of $35,145 thousand. Shares outstanding were 28,938,266 as of March 26, 2026. The prospectus supplement and 10-K highlight concentration risk (two customers ~30% and 23% of 2025 revenue), more than 270 employees, and IP and market-risk disclosures.